Cached score snapshot

US.RVTY · Revvity

110分制 56.2/110;5D動能v2 11/50;排序分 67.2/160

Ranking score 67.2/160
Main score 56.2/110
5D momentum v2 11/50
Rank #299
Setup grade F 33.4

Score breakdown

觀望

Elevated twelvedata

Score and price trend

F 33.4 Elevated risk

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

0 40 80 110 Score 07-23 09-15 10-23 11-10 11-26 $101.62$144.13$186.64 Price Projection date
Historical projection
Model Median P25/P75 歷史相似情境上漲比例 Down5 Actual / compare
Rolling DOE best · score 2.519 · anchors 120 +0.74% -0.75% / +2.27% 62.5% 5% Actual +0.84% · vs median +0.10% · inside 25-75 band
30D observation +4.86% +2.13% / +11.15% 82.5% 12.5% Actual outcome pending · 1 / 30 bars observed
Historical projection 10D n=160 +0.24% -1.22% / +2.42% 53.8% 5.6% Actual outcome pending · 1 / 10 bars observed

歷史情境統計基於已存檔相似 setup;圖中投影中位線為統計中位數的線性插值展示,並非價格路徑預測或買賣建議。

2026-07-23 → 2026-11-26 · 148 archived points · 6 Improving turn signal · 5 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 67.2
Display grade 觀望
Model version cursor_18_27_news_v2_160
Main score 56.2/110 (觀望)
5D momentum v2 11/50 (弱)
Score with momentum v2 67.2/160 (低排序)
Risk level Elevated

Audit trace

Full calculation detail

Calculation detail · 8 sections

Market inputs

Bar count 60
ma20 150.982
ma50 135.3566
close 154.71
prevClose 152.12
avgVolume20 2115039
volumeRatio 1.12
changePercent 1.7

Metrics snapshot

close 154.71
volume 2374788
changePercent 1.7

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 56.2/110
Main rating 觀望
5D momentum v2 11/50
Score with momentum v2 67.2/160
Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 2.4/5 · 較差

Dimension score 2.4/5
Dimension grade 較差

Sub-items

pbPoints 0.5
pePoints 0.2
epsPoints 0
roePoints 0
debtPoints 0.5
marginPoints 0
turnoverUsdM 367.4035
volumePoints 0.5
revenuePoints 0
dividendPoints 0.3
marketCapPoints 0.4

資金流 — 12.4/20 · 一般

Dimension score 12.4/20
Dimension grade 一般

Sub-items

cmfPoints 0.8
mfiPoints 3.2
obvPoints 2.4
vwapPoints 4

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL
symbol US.RVTY
message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional true
holderCount n/a
holderPoints 2
top10ShareRatio n/a
concentrationPenalty 0
institutionPoints 2

市場環境 — 10.2/15 · 一般

Dimension score 10.2/15
Dimension grade 一般

Sub-items

vix

score 2.4

details

source twelvedata+fred
vixClose 16.87

trend

score 3.4

details

qqq

ma20 743.1015
ma50 726.8704
name QQQ
close 728
points 1.4

spy

ma20 771.106
ma50 768.608
name SPY
close 771.79
points 2
source twelvedata+fred
atrPct 3.9216
atrPoints 2
cciPoints 2.4
vixPoints 2.4
marketTrendPoints 3.4

催化劑 — 2/20 · 較差

Dimension score 2/20
Dimension grade 較差

Sub-items

catalyst

score 2

details

source finnhub_news_keyword_model
articleCount 8
catalystCount 0
catalystPoints 2

風險管理 — 5.9/10 · 較差

Dimension score 5.9/10
Dimension grade 較差

Sub-items

position

score 1.3

details

atrPct 3.9216
turnoverUsdM 367.4035
liquidityPoints 0.6
volatilityPoints 0.7
rrPoints 1.4

stopLevels

symbol US.RVTY
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 142.5758

strength_details

ma_score 1.5
atr_score 1
rsi_score 2
macd_score 1.5
volume_score 2
market_adjustment 1
risk_reward_ratio 1
stop_loss_percent 7.8
take_profit_price 167.1981
target_multiplier 1.9
technical_strength 1.63
take_profit_percent 8.1
positionPoints 1.3
stopLossPoints 1.2

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 7.8432
diversificationPoints 2

技術信號 — 19.3/30 · 一般

Dimension score 19.3/30
Dimension grade 一般

Sub-items

bbPoints 3
adxPoints 3
sarPoints 1.2
vcpPoints 2.2
macdPoints 2.4

vcpPayload

vcp_pass false
vcp_score 2.2
vcp_reason 波幅收縮(29.3%→12.6%);跌縮量(近10日3日);站上MA50;Ready=Y;Confirm=N

vcp_metrics

up_days 5
vol_ref 2088023.3333
down_days 4
vcp_ready true
above_ma50 true
avg_vol_10 1738980
avg_vol_20 2133990
avg_vol_30 2088023.3333
range_pct_10 0.1264
range_pct_20 0.1692
range_pct_30 0.2931
up_expand_ok false
lookback_used 59
near_20d_high true
contraction_ok true
down_shrink_ok true
up_expand_days 1
breakout_20d_ok false
vol_ratio_10_30 0.8328
dist_to_20d_high 0.0694
down_shrink_days 3
breakout_level_20d 166.25
vcp_breakout_confirm false
contraction_ratio_10_30 0.4311
vcp_name_en Volatility Contraction Pattern
vcp_name_zh 波動收縮形態
vol_contraction true
kdjAdxPoints 0.5
rsiKdjPoints 2.4
volumeWeight 2
maCrossPoints 1.6
shortRsiPoints 0.8
shortMacdPoints 0.4
volConfirmPoints 0.6
volumePointsTechnical 1.2

情緒分析 — 4/10 · 較差

Dimension score 4/10
Dimension grade 較差

Sub-items

sentiment

score 4

details

source finnhub_news_keyword_model
articleCount 8
negativeHits 0
positiveHits 3
sentimentScoreRaw 0.9

sentimentData

raw {"id":142913436,"url":"https://finnhub.io/api/news?id=e01b57a1aa6db01da5aa5e2f48e508f0242d8475c162f68daecf96884fa9fb4f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"Revvity (RVTY) is back on investor calendars after announcing third quarter 2026 results are due on 3 November, with earnings per share expected to be higher and fresh conference appearances scheduled soon after. Revvity’s share price has surged over the past quarter, with a 30 day share price return of 18.4% and a 90 day gain of 36.2%. The 1 year total shareholder return of 65.6% contrasts with a weaker 5 year total shareholder return that is still down 12.8%, suggesting momentum has...","category":"company","datetime":1792062930,"headline":"Revvity (RVTY), What Is Drawing Fresh Attention Now?"}, {"id":142894962,"url":"https://finnhub.io/api/news?id=7a9a967625dcafa691a84760f6f658adee5a58425c6fda07f464d246eeb10b18","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"Revvity has delivered a strong share price run over the past year, and the key issue now is whether that market enthusiasm lines up with the cash the business can realistically generate. With the stock recently closing at US$152.12, investors are asking if the current tag fairly reflects the company’s underlying cash flows or if expectations are stretching ahead of what the business can support. Over the past 12 months, Revvity has returned 65.6%, which puts real weight on the question of...","category":"company","datetime":1792026927,"headline":"Revvity (RVTY) Stock Could Be 12% Stretched On Cash Flow"}, {"id":142592011,"url":"https://finnhub.io/api/news?id=1354c9a3ac86acca82d61b1988ec9d31e1f0743e2810cf95605e1c46072883de","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"Revvity (RVTY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).","category":"company","datetime":1790953202,"headline":"Revvity (RVTY) Upgraded to Buy: What Does It Mean for the Stock?"}, {"id":142499577,"url":"https://finnhub.io/api/news?id=ff4832de7ba97e9983ed854de2a013c27c693bf0523e62c4715efc273d08445c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"Revvity has been on fire lately. In the past six months alone, the company’s stock price has rocketed 78%, reaching $150.93 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.","category":"company","datetime":1790700002,"headline":"Revvity (RVTY): Buy, Sell, or Hold Post Q2 Earnings?"}, {"id":142423965,"url":"https://finnhub.io/api/news?id=a9ff4d3ba263b75cc7992bb9bb5763803e41a2e984ca6e0e139ac9d5b22bbd62","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"Revvity launches a CE-IVDR-certified automated T1D screening kit for children, expanding its GSP platform from newborn screening into early childhood.","category":"company","datetime":1790341740,"headline":"RVTY Launches New Kit in Europe for Newborn Type 1 Diabetes Detection"}, {"id":142350477,"url":"https://finnhub.io/api/news?id=cb58c8c8f2b541bcd7567cd8dc86f2dd0998a2a24d9e4da3258e8a9c57c37605","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"Revvity (RVTY) has drawn fresh attention after recent share price gains, with the stock up about 15% over the past month and roughly 36% over the past 3 months. Over the past year, Revvity has shifted from lagging long term returns, with a 5 year total shareholder return down 16.56%, to strong recent momentum. The 1 year total shareholder return reached 67.67%, and the 90 day share price return came in at 35.67%. Scan beyond Revvity's sharp rebound and explore other hand-picked opportunities...","category":"company","datetime":1790129530,"headline":"Why Revvity (RVTY) Is Getting Attention Today"}, {"id":142188758,"url":"https://finnhub.io/api/news?id=03b1bbe1a346d39ced2120c20af628767c205f491c25a175a480c992424683c9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"Revvity (RVTY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.","category":"company","datetime":1789550040,"headline":"Strength Seen in Revvity (RVTY): Can Its 9.1% Jump Turn into More Strength?"}, {"id":142162217,"url":"https://finnhub.io/api/news?id=c9e230170d179b85b200d044ccc0f27596b9851ed1649e5e94f0dc70a6ee1f7d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the research tools & consumables industry, including Revvity (NYSE:RVTY) and its peers.","category":"company","datetime":1789479331,"headline":"Q2 Rundown: Revvity (NYSE:RVTY) Vs Other Research Tools & Consumables Stocks"}
raw_source {"id":142913436,"url":"https://finnhub.io/api/news?id=e01b57a1aa6db01da5aa5e2f48e508f0242d8475c162f68daecf96884fa9fb4f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"Revvity (RVTY) is back on investor calendars after announcing third quarter 2026 results are due on 3 November, with earnings per share expected to be higher and fresh conference appearances scheduled soon after. Revvity’s share price has surged over the past quarter, with a 30 day share price return of 18.4% and a 90 day gain of 36.2%. The 1 year total shareholder return of 65.6% contrasts with a weaker 5 year total shareholder return that is still down 12.8%, suggesting momentum has...","category":"company","datetime":1792062930,"headline":"Revvity (RVTY), What Is Drawing Fresh Attention Now?"}, {"id":142906390,"url":"https://finnhub.io/api/news?id=5c850fabd074fba949692037137bcd030e692025571a7d5b2b7ed467985abb0f","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1728138175/image_1728138175.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"RVTY","summary":"While AI can design prospective drug molecules in seconds, validating whether they work still depends on slow physical wet-lab testing and custom testing tools.","category":"company","datetime":1792040640,"headline":"How To Invest In AI Drug Discovery"}, {"id":142894962,"url":"https://finnhub.io/api/news?id=7a9a967625dcafa691a84760f6f658adee5a58425c6fda07f464d246eeb10b18","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"Revvity has delivered a strong share price run over the past year, and the key issue now is whether that market enthusiasm lines up with the cash the business can realistically generate. With the stock recently closing at US$152.12, investors are asking if the current tag fairly reflects the company’s underlying cash flows or if expectations are stretching ahead of what the business can support. Over the past 12 months, Revvity has returned 65.6%, which puts real weight on the question of...","category":"company","datetime":1792026927,"headline":"Revvity (RVTY) Stock Could Be 12% Stretched On Cash Flow"}, {"id":142883187,"url":"https://finnhub.io/api/news?id=df66f5276cb53baa566420fe62459f6b065660547d648c42c6cc0bc813b10767","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"DGX heads into Q3 earnings with expected revenue and EPS growth, fueled by strong clinical demand, advanced diagnostics and operational efficiencies.","category":"company","datetime":1791979920,"headline":"Here's How Quest Diagnostics Is Placed Ahead of Q3 Earnings"}, {"id":142876719,"url":"https://finnhub.io/api/news?id=815d434e0657f117bffe7d1062a8fa7c74232073479b3c1504d9540821cd79e2","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds.","category":"company","datetime":1791971687,"headline":"3 Hyped Up Stocks We Think Twice About"}, {"id":142882355,"url":"https://finnhub.io/api/news?id=8042888ff6311b62097af82a31baa261ee19cca2862ead380bd66b34f5883b26","image":"https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_2.jpg?width=2048&height=1536","source":"Benzinga","related":"RVTY","summary":"Revvity (NYSE:RVTY) has outperformed the market over the past 15 years by 1.91% on an annualized basis producing an average annual return of 15.11%. Currently, Revvity has a market capitalization of $17.36 billion.","category":"company","datetime":1791918936,"headline":"Here's How Much $100 Invested In Revvity 15 Years Ago Would Be Worth Today"}, {"id":142851273,"url":"https://finnhub.io/api/news?id=89e904f7ec9123e4dd8479b5415fe596d2d08807c1cc886a77c4cd973f5b9ea8","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"TMO gears up for Q3 earnings, with revenue and EPS growth expected amid strong bioproduction demand, product innovations and clinical research strength.","category":"company","datetime":1791897900,"headline":"Thermo Fisher to Report Q3 Earnings: What's in the Cards?"}, {"id":142847674,"url":"https://finnhub.io/api/news?id=adebb5b294eb51be2e2bab0fb74566b676300da5221aea95f426696e0c6a6a9a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"WALTHAM, Mass., October 13, 2026--Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences:","category":"company","datetime":1791892800,"headline":"Revvity to Present at Upcoming Investor Conferences"}, {"id":142882356,"url":"https://finnhub.io/api/news?id=7212c13d3a03394ce412a77bb8f3f604130da5b24939c5f480c076a97a5ba191","image":"","source":"Benzinga","related":"RVTY","summary":"TD Cowen analyst Dan Brennan maintains Revvity (NYSE:RVTY) with a Buy and raises the price target from $130 to $175.","category":"company","datetime":1791892125,"headline":"TD Cowen Maintains Buy on Revvity, Raises Price Target to $175"}, {"id":142728921,"url":"https://finnhub.io/api/news?id=0dd7d1b383dd91d4ef55e272b4d0e25c1c563ddef68dfa481dcf459a3f0016fa","image":"https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp","source":"ChartMill","related":"RVTY","summary":"Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Thursday and stay ahead of the market trends.","category":"company","datetime":1791470101,"headline":"Which S&P500 stocks are gapping on Thursday?"}, {"id":142693767,"url":"https://finnhub.io/api/news?id=b58fc40ae5e598dea8cde16f52126f564cf1c2ee3879ed84982d201a4a9383d5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"281-Page Report Tracks Post-Pandemic Research Growth Across Pharma, Research and Industry/Cosmetic Users as 3D Assays, Automation and Immuno-oncology Reshape Drug DiscoveryDublin, Oct. 07, 2026 (GLOBE NEWSWIRE) -- \"Cell-Based Assay & High Content Screening Market 2025-2029 - Forecasts by User and Product, with Executive and Consultant Guides\" has been added to ResearchAndMarkets.com's offering. Research and Markets has published Cell-Based Assay & High Content Screening Market 2025-2029 - Foreca","category":"company","datetime":1791373560,"headline":"Cell-Based Assay & High Content Screening Market Report Reveals Why Technology Is Outpacing the Market, Profiling Thermo Fisher, Roche, Sartorius, Revvity & 50 Other Key Players"}, {"id":142728288,"url":"https://finnhub.io/api/news?id=8d9b36bda25cc3dae2a96a864dce6dd65b5b0892657a362c9ee1d7be1a2a3179","image":"","source":"Benzinga","related":"RVTY","summary":"Barclays analyst Luke Sergott maintains Revvity (NYSE:RVTY) with a Equal-Weight and raises the price target from $115 to $160.","category":"company","datetime":1791372093,"headline":"Barclays Maintains Equal-Weight on Revvity, Raises Price Target to $160"}, {"id":142697475,"url":"https://finnhub.io/api/news?id=5293fb6cb9cd661ac9f7d6788a377cca7b6432efc60ab2ab7a30c515d13e581b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"Revvity will release its third-quarter earnings next month, and analysts anticipate a high single-digit bottom-line growth.","category":"company","datetime":1791363263,"headline":"Revvity Earnings Preview: What to Expect"}, {"id":142694619,"url":"https://finnhub.io/api/news?id=1ca703b7fad07089c730aef2b5ff799b55d0fa3971297d860aacc4957655612f","image":"","source":"Benzinga","related":"RVTY","summary":"William Blair analyst Matt Larew initiates coverage on Revvity (NYSE:RVTY) with a Outperform rating.","category":"company","datetime":1791303270,"headline":"William Blair Initiates Coverage On Revvity with Outperform Rating"}, {"id":142694620,"url":"https://finnhub.io/api/news?id=947600016a722f37a30f498b8ac2a29d931f9e0e2fe0b9640f578c701ecc477d","image":"https://cdn.benzinga.com/files/images/story/2026/10/06/Revvity-Inc.jpg?width=2048&height=1536","source":"Benzinga","related":"RVTY","summary":"William Blair initiates Revvity (RVTY) at Outperform, citing AI tailwinds, life sciences recovery, and potential 20%+ stock upside.","category":"company","datetime":1791298272,"headline":"Revvity Nears 52-Week High, but This Analyst Thinks Stock Can Climb Another 20%"}, {"id":142663473,"url":"https://finnhub.io/api/news?id=77771d918fee3d8e31646d64918184c9a6dda8db8f26fbdf378ad0829d4dcbf5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"WALTHAM, Mass., October 06, 2026--Revvity, Inc. (NYSE: RVTY), today announced it will host its 2026 Investor Day on Friday, November 13 at 9:00 a.m. ET.","category":"company","datetime":1791288000,"headline":"Revvity to Host Investor Day"}, {"id":142592011,"url":"https://finnhub.io/api/news?id=1354c9a3ac86acca82d61b1988ec9d31e1f0743e2810cf95605e1c46072883de","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"Revvity (RVTY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).","category":"company","datetime":1790953202,"headline":"Revvity (RVTY) Upgraded to Buy: What Does It Mean for the Stock?"}, {"id":142588838,"url":"https://finnhub.io/api/news?id=20f528af1e1b120c026025dfda2cdf1c613fc223627e530195c33ed1dffc0e4d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"WALTHAM, Mass., October 02, 2026--Revvity, Inc. (NYSE: RVTY), today announced that it will release its third quarter 2026 financial results prior to market open on Tuesday, November 3, 2026. The Company will host a conference call the same day at 7:30 a.m. ET to discuss these results. Prahlad Singh, president and chief executive officer, and Max Krakowiak, chief financial officer, will host the conference call.","category":"company","datetime":1790942400,"headline":"Revvity to Hold Earnings Call on November 3, 2026"}, {"id":142521568,"url":"https://finnhub.io/api/news?id=8796fb4f75396d1828b23a3b1b8c40d67fff4a675fd7b4ca8feac4460090c598","image":"https://www.chartmill.com/images/uploads/CM_Unusual_Volume_Small_free_b9d2e60841.webp","source":"ChartMill","related":"RVTY","summary":"Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Wednesday. Stay informed about the market activity below.","category":"company","datetime":1790787900,"headline":"Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session."}, {"id":142499577,"url":"https://finnhub.io/api/news?id=ff4832de7ba97e9983ed854de2a013c27c693bf0523e62c4715efc273d08445c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"Revvity has been on fire lately. In the past six months alone, the company’s stock price has rocketed 78%, reaching $150.93 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.","category":"company","datetime":1790700002,"headline":"Revvity (RVTY): Buy, Sell, or Hold Post Q2 Earnings?"}, {"id":142498306,"url":"https://finnhub.io/api/news?id=b99b47066bf1db0d53f43dfd46ad34ae8002db612643d2fa307c56c3e05fdaf9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"RVTY's diagnostics growth, AI-driven demand and life sciences expansion support its outlook, though China and margin pressures pose near-term challenges.","category":"company","datetime":1790687520,"headline":"Here's Why You Should Retain Revvity Stock in Your Portfolio for Now"}, {"id":142463267,"url":"https://finnhub.io/api/news?id=fc9a13a952922c8e6a07e852b9dc7e22771cf21ad57968453bc3b6669662339b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.","category":"company","datetime":1790586156,"headline":"1 Unpopular Stock That Deserves Some Love and 2 Facing Headwinds"}, {"id":142423965,"url":"https://finnhub.io/api/news?id=a9ff4d3ba263b75cc7992bb9bb5763803e41a2e984ca6e0e139ac9d5b22bbd62","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"Revvity launches a CE-IVDR-certified automated T1D screening kit for children, expanding its GSP platform from newborn screening into early childhood.","category":"company","datetime":1790341740,"headline":"RVTY Launches New Kit in Europe for Newborn Type 1 Diabetes Detection"}, {"id":142423581,"url":"https://finnhub.io/api/news?id=6c773b4b4fd56046165f9f939d6d09120e989435edcb977079470afccf6c629d","image":"https://cdn.benzinga.com/files/images/story/2025/11/06/movers_2.jpg?width=2048&height=1536","source":"Benzinga","related":"RVTY","summary":"Revvity (NYSE:RVTY) reported second-quarter financial results on Tuesday. The transcript from the company's second-quarter earnings call has been provided below.\nThis content is powered by Benzinga APIs. For","category":"company","datetime":1790313777,"headline":"Full Transcript: Revvity Q2 2026 Earnings Call"}, {"id":142385877,"url":"https://finnhub.io/api/news?id=0a10ab9058f099ea9dd8fed3a27d11f516b03ecf689b3ca7ecb544bfc4264f7b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"Healthcare stocks were higher late Thursday afternoon, with the NYSE Healthcare Index increasing 0.9","category":"company","datetime":1790280084,"headline":"Sector Update: Healthcare Stocks Advance Late Afternoon"}, {"id":142385317,"url":"https://finnhub.io/api/news?id=f6f2a26b9f5647288b5da04eda91284fe1679478b8b585e97013ed1ba637efe8","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"RVTY","summary":"Stay updated with the movements of the S&P500 index one hour before the close of the markets on Thursday. Discover which stocks are leading as top gainers and losers in today's session.","category":"company","datetime":1790276701,"headline":"Discover which S&P500 stocks are making waves on Thursday."}, {"id":142423582,"url":"https://finnhub.io/api/news?id=dbcf2dda78e5857b21e4ffb41aceed01250ceb475132a6bb612a945f2768a415","image":"https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_4.jpg?width=2048&height=1536","source":"Benzinga","related":"RVTY","summary":"Revvity (NYSE:RVTY) has outperformed the market over the past 15 years by 1.11% on an annualized basis producing an average annual return of 14.72%. Currently, Revvity has a market capitalization of $16.82 billion.","category":"company","datetime":1790271929,"headline":"Here’s How Much You Would Have Made Owning Revvity Stock In The Last 15 Years"}, {"id":142384739,"url":"https://finnhub.io/api/news?id=064fca65c12d5a6a144b02ffa288fa39c2b8d29421fbe717d8ae80b17cdacb6f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"All three major US stock indexes fell in late-morning trading Thursday amid uncertainty in the Middl","category":"company","datetime":1790265971,"headline":"Top Midday Stories: Oracle's Data Center Delay; People Withdraws MGM Offer; Revvity's New Diabetes Test"}, {"id":142374834,"url":"https://finnhub.io/api/news?id=57a218c79f8db9c5829dc0b25bcf5d3d5d2d104a3cb88128bac31f9d804f3aa9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"WALTHAM, Mass., September 24, 2026--Revvity, Inc. (NYSE: RVTY) today announced the launch of the GSP® T1D 3plex kit, a fully automated, CE-IVDR-certified, multiplex autoantibody (AAb) detection solution to enable population-wide screening programs that identify children at risk of developing type 1 diabetes (T1D) before symptoms appear.","category":"company","datetime":1790251200,"headline":"Revvity Launches IVDR-Certified Solution for Early Detection of Type 1 Diabetes"}, {"id":142379627,"url":"https://finnhub.io/api/news?id=6f5fae7103718fad61d71f792ffe7fcab9e945543672660195665d850dedefdd","image":"","source":"Benzinga","related":"RVTY","summary":"Revvity, Inc. (NYSE: RVTY) today announced the launch of the GSP® T1D 3plex kit, a fully automated, CE-IVDR-certified, multiplex autoantibody (AAb) detection solution to enable population-wide screening programs that","category":"company","datetime":1790237027,"headline":"Revvity Rolls Out GSP T1D 3plex Kit"}, {"id":142363351,"url":"https://finnhub.io/api/news?id=08e21debb549e8d7bd2c4b8c5893e45852ed71ecc7711b290ef91bf21303ffcf","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"Revvity has notably outperformed the Dow over the past year, and analysts are moderately optimistic about the stock’s prospects.","category":"company","datetime":1790159593,"headline":"Is Revvity Stock Outperforming the Dow?"}, {"id":142350477,"url":"https://finnhub.io/api/news?id=cb58c8c8f2b541bcd7567cd8dc86f2dd0998a2a24d9e4da3258e8a9c57c37605","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"Revvity (RVTY) has drawn fresh attention after recent share price gains, with the stock up about 15% over the past month and roughly 36% over the past 3 months. Over the past year, Revvity has shifted from lagging long term returns, with a 5 year total shareholder return down 16.56%, to strong recent momentum. The 1 year total shareholder return reached 67.67%, and the 90 day share price return came in at 35.67%. Scan beyond Revvity's sharp rebound and explore other hand-picked opportunities...","category":"company","datetime":1790129530,"headline":"Why Revvity (RVTY) Is Getting Attention Today"}, {"id":142328474,"url":"https://finnhub.io/api/news?id=85efb7d8043da2785c44589fe07e464369b52343ea3a62c863b956ea862cb220","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"AI-enabled, microfluidic label-free detection is expanding in drug discovery, early diagnostics, food safety and environmental testing, driven by efficient, non-invasive, sustainable workflows.Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- \"Label-Free Detection - Global Strategic Business Report\" has been added to ResearchAndMarkets.com's offering.The global market for Label-Free Detection was valued at US$553 Million in 2024 and is projected to reach US$847 Million by 2030, growing at a CAGR of 7.4","category":"company","datetime":1790065560,"headline":"Capitalize on the Label-Free Detection Market Shift: Track How Danaher, Sartorius, Agilent, Bruker and Revvity Are Disrupting R&D ROI and Reshaping Global Revenue Through 2030"}, {"id":142328487,"url":"https://finnhub.io/api/news?id=293df837bbb17c71cf269b411ac0010b830920bae67dc70e20edcee04009550a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"High-content screening is advancing drug discovery and personalized medicine, driven by 3D models, advanced imaging and automated analytics, with opportunities in cancer research and organoids.Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- \"High Content Screening (HCS) - Global Strategic Business Report\" has been added to ResearchAndMarkets.com's offering.The global market for High Content Screening (HCS) was valued at US$1.3 Billion in 2024 and is projected to reach US$2.2 Billion by 2030, growing","category":"company","datetime":1790065140,"headline":"Capitalize on High Content Screening Disruption: Decode How Thermo Fisher Scientific, Danaher, Revvity, and Yokogawa Are Reshaping Global R&D ROI and Revenue"}, {"id":142269870,"url":"https://finnhub.io/api/news?id=97da2091fb37a98868cc4df2c623e9c31db2fd3283341dda1e7fd6b0739faf09","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2149954800/image_2149954800.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"RVTY","summary":"U.S. stocks closed the week mixed as Treasury yields rose amid a Fed rate hike, and fears of AI development grew. Read more about this week's top events on Wall Street.","category":"company","datetime":1789800247,"headline":"What Moved Markets This Week"}, {"id":142270772,"url":"https://finnhub.io/api/news?id=2fbac1a765a47bf212e99e40ad93c0b49a5ff423030f1a4db735d13f67e98fb2","image":"https://cdn.benzinga.com/files/images/story/2026/09/18/Diesel-Prices-Cross-6.jpg?width=2048&height=1536","source":"Benzinga","related":"RVTY","summary":"The Fed hiked for the first time since 2023; the 10-year yield touched 5.04%, and record diesel prices hit truckers and automakers.","category":"company","datetime":1789747909,"headline":"Fed Raises Rates, Yields Hit 2007 Highs as Fuel Costs Set Records: This Week On Wall Street"}, {"id":142249608,"url":"https://finnhub.io/api/news?id=713a37af216447ec3bd78a404d516aab7a7639f9e3cf8a77d99b3839d2ffcb44","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or even a loyal Reddit fanbase.","category":"company","datetime":1789719440,"headline":"1 Momentum Stock with Promising Prospects and 2 Facing Headwinds"}, {"id":142198959,"url":"https://finnhub.io/api/news?id=568783958075196b65740530debea12cb32f6534984a1b55719ef4f7c7471b7c","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"RVTY","summary":"Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session.","category":"company","datetime":1789585501,"headline":"Explore the top gainers and losers within the S&P500 index in today's session."}, {"id":142188758,"url":"https://finnhub.io/api/news?id=03b1bbe1a346d39ced2120c20af628767c205f491c25a175a480c992424683c9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"Revvity (RVTY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.","category":"company","datetime":1789550040,"headline":"Strength Seen in Revvity (RVTY): Can Its 9.1% Jump Turn into More Strength?"}, {"id":142167113,"url":"https://finnhub.io/api/news?id=b9533ba462e02bc4cdd69ebe009cce3b112c1338397a301218653d5b059ea426","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"RVTY","summary":"Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.","category":"company","datetime":1789499101,"headline":"Discover which S&P500 stocks are making waves on Tuesday."}, {"id":142162217,"url":"https://finnhub.io/api/news?id=c9e230170d179b85b200d044ccc0f27596b9851ed1649e5e94f0dc70a6ee1f7d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the research tools & consumables industry, including Revvity (NYSE:RVTY) and its peers.","category":"company","datetime":1789479331,"headline":"Q2 Rundown: Revvity (NYSE:RVTY) Vs Other Research Tools & Consumables Stocks"}, {"id":142194774,"url":"https://finnhub.io/api/news?id=d1cab808ccf45cf13f1263e44cacc1adc587155103fca3659b6bbe4aa4db95f1","image":"https://cdn.benzinga.com/files/images/story/2026/09/15/Stock-Market-Graph-Crashing-Down--Wall-S.jpg?width=2048&height=1536","source":"Benzinga","related":"RVTY","summary":"The 10-year Treasury yield broke 5% for the first time since 2007 as WTI surged past $105 on Saudi pipeline outages, pressuring stocks ahead of the Fed.","category":"company","datetime":1789478829,"headline":"10-Year Yield Tops 5%, Oil Storms Past $105: Stock Market Today"}, {"id":142165183,"url":"https://finnhub.io/api/news?id=41ebfd4b80544d2c7c619a56a61cee031e3049ed69310da56b5dd1c7a7151515","image":"https://image.cnbcfm.com/api/v1/image/108326254-1782318177071-gettyimages-2213364616-img_9901.jpeg?v=1782318352&w=1920&h=1080","source":"CNBC","related":"RVTY","summary":"These are the stocks posting the largest moves midday.","category":"company","datetime":1789473808,"headline":"Stocks making the biggest moves midday: Skyworks Solutions, Axon, Dave & Buster's, Revvity & more"}, {"id":142164499,"url":"https://finnhub.io/api/news?id=a187851a3b32d0f518cf6a22cdf7cb457662bd37fcebf1db3d2d732edf49b488","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"RVTY","summary":"Revvity, Inc. (RVTY) 2026 Global Healthcare Conference September 15, 2026 9:05 AM EDTCompany ParticipantsStephen Willoughby - Senior VP of Investor...","category":"company","datetime":1789473097,"headline":"Revvity, Inc. (RVTY) Presents at 2026 Global Healthcare Conference Transcript"}
data_source finnhub_news_keyword_model
article_count 8
negative_hits 0
positive_hits 3
recomputed_at_score true
sentiment_score_raw 0.9
source_article_count 44
discarded_article_count 35
sentimentPoints 4

Dimension contribution

Dimension Raw Max Norm % Contrib
基本面 2.4 5/110 48% 2.4
資金流 12.4 20/110 62% 12.4
市場環境 10.2 15/110 68% 10.2
催化劑 2 20/110 10% 2
風險管理 5.9 10/110 59% 5.9
技術信號 19.3 30/110 64.33% 19.3
情緒分析 4 10/110 40% 4

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 11/50
ret_5d 0.0168
max_score 50
max_total 50
raw_total 11
vcp_bonus 0
vol_ratio 1.1128
ret_points 4
vol_points 2
range_ratio 1.4133
volat_points 2
day_range_pct 0.0519
model_version cursor_18_27_news_v2_160
available_bars 30
breakout_points 0
partial_history false
pullback_points 3
breakout_vol_bonus 0
first_breakout_20d false
return_window_days 5
first_breakout_bonus 0
breakout_quality_points 0

Risk management

level Elevated
reason risk management score >= 5/10

position

score 1.3

details

atrPct 3.9216
turnoverUsdM 367.4035
liquidityPoints 0.6
volatilityPoints 0.7
rrPoints 1.4

stopLevels

symbol US.RVTY
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 142.5758

strength_details

ma_score 1.5
atr_score 1
rsi_score 2
macd_score 1.5
volume_score 2
market_adjustment 1
risk_reward_ratio 1
stop_loss_percent 7.8
take_profit_price 167.1981
target_multiplier 1.9
technical_strength 1.63
take_profit_percent 8.1
positionPoints 1.3
stopLossPoints 1.2

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 7.8432
diversificationPoints 2

Calculation audit log

基本面分析總分: 2.4/5分
資金流分析總分: 12.4/20分
市場環境分析總分: 10.2/15分
催化劑分析: 2/20分
風險管理總分: 5.9/10分
技術信號分析總分: 19.3/30分
情緒分析: 4/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx
value 85.71
atr
atr 6.0671
rule ATR / current price; lower volatility scores higher
score 4
atr_pct 3.92
cci
rule Cursor_18.24 CCI bands
level 平衡
score 6
value 49.79
cmf
rule Cursor_18.24 CMF bands
level 派發
score 2
value -0.0272
kdj
d 43.57
j 30.98
k 39.37
rule Cursor_18.24 K/D cross
score 0
signal 死叉
mfi
rule Cursor_18.24 MFI bands
level 入貨中
score 8
value 61.57
obv
rule Cursor_18.24 recent_slope vs previous_slope
score 6
trend 有流入
value 14195788
recentSlope 95238.8
previousSlope 473520
rsi
value 56.12
sar
rule Cursor_18.24 Parabolic SAR
score 4
trend 下降
value 165.4055
position SAR喺價上
distancePct 6.91
previousTrend 下降
ma50
value 135.3566
macd
macd 5.5305
trend 中性偏多
signal 6.3159
histogram -0.7854
vwap
rule Cursor_18.24 VWAP 20D consecutive close
score 10
value 150.5339
position 連續5日>VWAP
consecutiveAbove 24
volume
rule Cursor_18.24 volume ratio
level 有量
ratio 1.12
score 6
avgVolume 2115039
currentVolume 2374788
derived
ma20 150.982
ma50 135.3566
prevClose 152.12
avgVolume10 1728079
avgVolume20 2115039
changePercent 1.7
avgVolumeForScore 2115039
ma_cross
ma20 150.982
ma50 135.3566
rule Cursor_18.24 MA20/MA50 cross
cross 多頭
score 4
prevMa20 150.583
prevMa50 134.5628
spreadPct 11.54
isVolumeBreakout false
bollinger
lower 142.2893
upper 159.6747
position 上半部
rsi_short
value 55.06
macd_short
macd 0
trend 中性
signal 0
histogram 0
volume_ratio
ratio 1.12

Raw calculation JSON

{
  "risk": {
    "level": "Elevated",
    "reason": "risk management score >= 5/10",
    "position": {
      "score": 1.3,
      "details": {
        "atrPct": 3.9215949892317887,
        "turnoverUsdM": 367.40347522788,
        "liquidityPoints": 0.6,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.RVTY",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 142.5758,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 1,
        "rsi_score": 2,
        "macd_score": 1.5,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 7.8,
      "take_profit_price": 167.1981,
      "target_multiplier": 1.9,
      "technical_strength": 1.63,
      "take_profit_percent": 8.1
    },
    "positionPoints": 1.3,
    "stopLossPoints": 1.2,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 7.8431899784635775,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 67.2,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 56.2,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 11
  },
  "market": {
    "ma20": 150.982,
    "ma50": 135.3566,
    "close": 154.71,
    "prevClose": 152.12,
    "avgVolume20": 2115039,
    "volumeRatio": 1.12,
    "changePercent": 1.7
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 11,
    "details": {
      "ret_5d": 0.016758740799158955,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 11,
      "vcp_bonus": 0,
      "vol_ratio": 1.112839329143998,
      "ret_points": 4,
      "vol_points": 2,
      "range_ratio": 1.4132504389587675,
      "volat_points": 2,
      "day_range_pct": 0.051903558147271794,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 67.2,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.4,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 48,
        "contribution": 2.4
      },
      {
        "raw": 12.4,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 62,
        "contribution": 12.4
      },
      {
        "raw": 10.2,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 68,
        "contribution": 10.2
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 5.9,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 59,
        "contribution": 5.9
      },
      {
        "raw": 19.3,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 64.33,
        "contribution": 19.3
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 56.2,
    "details": [
      "基本面分析總分: 2.4/5分",
      "資金流分析總分: 12.4/20分",
      "市場環境分析總分: 10.2/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 5.9/10分",
      "技術信號分析總分: 19.3/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.4,
      "資金流": 12.4,
      "市場環境": 10.2,
      "情緒分析": 4,
      "技術信號": 19.3,
      "風險管理": 5.9
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.5,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 367.40347522788,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.4
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "一般",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 3.2,
          "obvPoints": 2.4,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.RVTY",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "一般",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 16.87
            }
          },
          "trend": {
            "score": 3.4,
            "details": {
              "qqq": {
                "ma20": 743.10150415,
                "ma50": 726.8704012600002,
                "name": "QQQ",
                "close": 728,
                "points": 1.4
              },
              "spy": {
                "ma20": 771.10599665,
                "ma50": 768.6079965800001,
                "name": "SPY",
                "close": 771.78998,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 3.9215949892317887,
          "atrPoints": 2,
          "cciPoints": 2.4,
          "vixPoints": 2.4,
          "marketTrendPoints": 3.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 3,
              "sentimentScoreRaw": 0.9
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 142913436,
                "url": "https://finnhub.io/api/news?id=e01b57a1aa6db01da5aa5e2f48e508f0242d8475c162f68daecf96884fa9fb4f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity (RVTY) is back on investor calendars after announcing third quarter 2026 results are due on 3 November, with earnings per share expected to be higher and fresh conference appearances scheduled soon after. Revvity’s share price has surged over the past quarter, with a 30 day share price return of 18.4% and a 90 day gain of 36.2%. The 1 year total shareholder return of 65.6% contrasts with a weaker 5 year total shareholder return that is still down 12.8%, suggesting momentum has...",
                "category": "company",
                "datetime": 1792062930,
                "headline": "Revvity (RVTY), What Is Drawing Fresh Attention Now?"
              },
              {
                "id": 142894962,
                "url": "https://finnhub.io/api/news?id=7a9a967625dcafa691a84760f6f658adee5a58425c6fda07f464d246eeb10b18",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity has delivered a strong share price run over the past year, and the key issue now is whether that market enthusiasm lines up with the cash the business can realistically generate. With the stock recently closing at US$152.12, investors are asking if the current tag fairly reflects the company’s underlying cash flows or if expectations are stretching ahead of what the business can support. Over the past 12 months, Revvity has returned 65.6%, which puts real weight on the question of...",
                "category": "company",
                "datetime": 1792026927,
                "headline": "Revvity (RVTY) Stock Could Be 12% Stretched On Cash Flow"
              },
              {
                "id": 142592011,
                "url": "https://finnhub.io/api/news?id=1354c9a3ac86acca82d61b1988ec9d31e1f0743e2810cf95605e1c46072883de",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity (RVTY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).",
                "category": "company",
                "datetime": 1790953202,
                "headline": "Revvity (RVTY) Upgraded to Buy: What Does It Mean for the Stock?"
              },
              {
                "id": 142499577,
                "url": "https://finnhub.io/api/news?id=ff4832de7ba97e9983ed854de2a013c27c693bf0523e62c4715efc273d08445c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity has been on fire lately. In the past six months alone, the company’s stock price has rocketed 78%, reaching $150.93 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.",
                "category": "company",
                "datetime": 1790700002,
                "headline": "Revvity (RVTY): Buy, Sell, or Hold Post Q2 Earnings?"
              },
              {
                "id": 142423965,
                "url": "https://finnhub.io/api/news?id=a9ff4d3ba263b75cc7992bb9bb5763803e41a2e984ca6e0e139ac9d5b22bbd62",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity launches a CE-IVDR-certified automated T1D screening kit for children, expanding its GSP platform from newborn screening into early childhood.",
                "category": "company",
                "datetime": 1790341740,
                "headline": "RVTY Launches New Kit in Europe for Newborn Type 1 Diabetes Detection"
              },
              {
                "id": 142350477,
                "url": "https://finnhub.io/api/news?id=cb58c8c8f2b541bcd7567cd8dc86f2dd0998a2a24d9e4da3258e8a9c57c37605",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity (RVTY) has drawn fresh attention after recent share price gains, with the stock up about 15% over the past month and roughly 36% over the past 3 months. Over the past year, Revvity has shifted from lagging long term returns, with a 5 year total shareholder return down 16.56%, to strong recent momentum. The 1 year total shareholder return reached 67.67%, and the 90 day share price return came in at 35.67%. Scan beyond Revvity's sharp rebound and explore other hand-picked opportunities...",
                "category": "company",
                "datetime": 1790129530,
                "headline": "Why Revvity (RVTY) Is Getting Attention Today"
              },
              {
                "id": 142188758,
                "url": "https://finnhub.io/api/news?id=03b1bbe1a346d39ced2120c20af628767c205f491c25a175a480c992424683c9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity (RVTY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.",
                "category": "company",
                "datetime": 1789550040,
                "headline": "Strength Seen in Revvity (RVTY): Can Its 9.1% Jump Turn into More Strength?"
              },
              {
                "id": 142162217,
                "url": "https://finnhub.io/api/news?id=c9e230170d179b85b200d044ccc0f27596b9851ed1649e5e94f0dc70a6ee1f7d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the research tools & consumables industry, including Revvity (NYSE:RVTY) and its peers.",
                "category": "company",
                "datetime": 1789479331,
                "headline": "Q2 Rundown: Revvity (NYSE:RVTY) Vs Other Research Tools & Consumables Stocks"
              }
            ],
            "raw_source": [
              {
                "id": 142913436,
                "url": "https://finnhub.io/api/news?id=e01b57a1aa6db01da5aa5e2f48e508f0242d8475c162f68daecf96884fa9fb4f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity (RVTY) is back on investor calendars after announcing third quarter 2026 results are due on 3 November, with earnings per share expected to be higher and fresh conference appearances scheduled soon after. Revvity’s share price has surged over the past quarter, with a 30 day share price return of 18.4% and a 90 day gain of 36.2%. The 1 year total shareholder return of 65.6% contrasts with a weaker 5 year total shareholder return that is still down 12.8%, suggesting momentum has...",
                "category": "company",
                "datetime": 1792062930,
                "headline": "Revvity (RVTY), What Is Drawing Fresh Attention Now?"
              },
              {
                "id": 142906390,
                "url": "https://finnhub.io/api/news?id=5c850fabd074fba949692037137bcd030e692025571a7d5b2b7ed467985abb0f",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1728138175/image_1728138175.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "RVTY",
                "summary": "While AI can design prospective drug molecules in seconds, validating whether they work still depends on slow physical wet-lab testing and custom testing tools.",
                "category": "company",
                "datetime": 1792040640,
                "headline": "How To Invest In AI Drug Discovery"
              },
              {
                "id": 142894962,
                "url": "https://finnhub.io/api/news?id=7a9a967625dcafa691a84760f6f658adee5a58425c6fda07f464d246eeb10b18",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity has delivered a strong share price run over the past year, and the key issue now is whether that market enthusiasm lines up with the cash the business can realistically generate. With the stock recently closing at US$152.12, investors are asking if the current tag fairly reflects the company’s underlying cash flows or if expectations are stretching ahead of what the business can support. Over the past 12 months, Revvity has returned 65.6%, which puts real weight on the question of...",
                "category": "company",
                "datetime": 1792026927,
                "headline": "Revvity (RVTY) Stock Could Be 12% Stretched On Cash Flow"
              },
              {
                "id": 142883187,
                "url": "https://finnhub.io/api/news?id=df66f5276cb53baa566420fe62459f6b065660547d648c42c6cc0bc813b10767",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "DGX heads into Q3 earnings with expected revenue and EPS growth, fueled by strong clinical demand, advanced diagnostics and operational efficiencies.",
                "category": "company",
                "datetime": 1791979920,
                "headline": "Here's How Quest Diagnostics Is Placed Ahead of Q3 Earnings"
              },
              {
                "id": 142876719,
                "url": "https://finnhub.io/api/news?id=815d434e0657f117bffe7d1062a8fa7c74232073479b3c1504d9540821cd79e2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds.",
                "category": "company",
                "datetime": 1791971687,
                "headline": "3 Hyped Up  Stocks We Think Twice About"
              },
              {
                "id": 142882355,
                "url": "https://finnhub.io/api/news?id=8042888ff6311b62097af82a31baa261ee19cca2862ead380bd66b34f5883b26",
                "image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_2.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "RVTY",
                "summary": "Revvity (NYSE:RVTY) has outperformed the market over the past 15 years by 1.91% on an annualized basis producing an average annual return of 15.11%. Currently, Revvity has a market capitalization of $17.36 billion.",
                "category": "company",
                "datetime": 1791918936,
                "headline": "Here's How Much $100 Invested In Revvity 15 Years Ago Would Be Worth Today"
              },
              {
                "id": 142851273,
                "url": "https://finnhub.io/api/news?id=89e904f7ec9123e4dd8479b5415fe596d2d08807c1cc886a77c4cd973f5b9ea8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "TMO gears up for Q3 earnings, with revenue and EPS growth expected amid strong bioproduction demand, product innovations and clinical research strength.",
                "category": "company",
                "datetime": 1791897900,
                "headline": "Thermo Fisher to Report Q3 Earnings: What's in the Cards?"
              },
              {
                "id": 142847674,
                "url": "https://finnhub.io/api/news?id=adebb5b294eb51be2e2bab0fb74566b676300da5221aea95f426696e0c6a6a9a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "WALTHAM, Mass., October 13, 2026--Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences:",
                "category": "company",
                "datetime": 1791892800,
                "headline": "Revvity to Present at Upcoming Investor Conferences"
              },
              {
                "id": 142882356,
                "url": "https://finnhub.io/api/news?id=7212c13d3a03394ce412a77bb8f3f604130da5b24939c5f480c076a97a5ba191",
                "image": "",
                "source": "Benzinga",
                "related": "RVTY",
                "summary": "TD Cowen  analyst Dan Brennan   maintains Revvity (NYSE:RVTY) with a Buy and raises the price target from $130 to $175.",
                "category": "company",
                "datetime": 1791892125,
                "headline": "TD Cowen Maintains Buy on Revvity, Raises Price Target to $175"
              },
              {
                "id": 142728921,
                "url": "https://finnhub.io/api/news?id=0dd7d1b383dd91d4ef55e272b4d0e25c1c563ddef68dfa481dcf459a3f0016fa",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "RVTY",
                "summary": "Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Thursday and stay ahead of the market trends.",
                "category": "company",
                "datetime": 1791470101,
                "headline": "Which S&P500 stocks are gapping on Thursday?"
              },
              {
                "id": 142693767,
                "url": "https://finnhub.io/api/news?id=b58fc40ae5e598dea8cde16f52126f564cf1c2ee3879ed84982d201a4a9383d5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "281-Page Report Tracks Post-Pandemic Research Growth Across Pharma, Research and Industry/Cosmetic Users as 3D Assays, Automation and Immuno-oncology Reshape Drug DiscoveryDublin, Oct. 07, 2026 (GLOBE NEWSWIRE) -- \"Cell-Based Assay & High Content Screening Market 2025-2029 - Forecasts by User and Product, with Executive and Consultant Guides\" has been added to ResearchAndMarkets.com's offering. Research and Markets has published Cell-Based Assay & High Content Screening Market 2025-2029 - Foreca",
                "category": "company",
                "datetime": 1791373560,
                "headline": "Cell-Based Assay & High Content Screening Market Report Reveals Why Technology Is Outpacing the Market, Profiling Thermo Fisher, Roche, Sartorius, Revvity & 50 Other Key Players"
              },
              {
                "id": 142728288,
                "url": "https://finnhub.io/api/news?id=8d9b36bda25cc3dae2a96a864dce6dd65b5b0892657a362c9ee1d7be1a2a3179",
                "image": "",
                "source": "Benzinga",
                "related": "RVTY",
                "summary": "Barclays  analyst Luke Sergott   maintains Revvity (NYSE:RVTY) with a Equal-Weight and raises the price target from $115 to $160.",
                "category": "company",
                "datetime": 1791372093,
                "headline": "Barclays Maintains Equal-Weight on Revvity, Raises Price Target to $160"
              },
              {
                "id": 142697475,
                "url": "https://finnhub.io/api/news?id=5293fb6cb9cd661ac9f7d6788a377cca7b6432efc60ab2ab7a30c515d13e581b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity will release its third-quarter earnings next month, and analysts anticipate a high single-digit bottom-line growth.",
                "category": "company",
                "datetime": 1791363263,
                "headline": "Revvity Earnings Preview: What to Expect"
              },
              {
                "id": 142694619,
                "url": "https://finnhub.io/api/news?id=1ca703b7fad07089c730aef2b5ff799b55d0fa3971297d860aacc4957655612f",
                "image": "",
                "source": "Benzinga",
                "related": "RVTY",
                "summary": "William Blair  analyst Matt Larew   initiates coverage on Revvity (NYSE:RVTY) with a Outperform rating.",
                "category": "company",
                "datetime": 1791303270,
                "headline": "William Blair Initiates Coverage On Revvity with Outperform Rating"
              },
              {
                "id": 142694620,
                "url": "https://finnhub.io/api/news?id=947600016a722f37a30f498b8ac2a29d931f9e0e2fe0b9640f578c701ecc477d",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/06/Revvity-Inc.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "RVTY",
                "summary": "William Blair initiates Revvity (RVTY) at Outperform, citing AI tailwinds, life sciences recovery, and potential 20%+ stock upside.",
                "category": "company",
                "datetime": 1791298272,
                "headline": "Revvity Nears 52-Week High, but This Analyst Thinks Stock Can Climb Another 20%"
              },
              {
                "id": 142663473,
                "url": "https://finnhub.io/api/news?id=77771d918fee3d8e31646d64918184c9a6dda8db8f26fbdf378ad0829d4dcbf5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "WALTHAM, Mass., October 06, 2026--Revvity, Inc. (NYSE: RVTY), today announced it will host its 2026 Investor Day on Friday, November 13 at 9:00 a.m. ET.",
                "category": "company",
                "datetime": 1791288000,
                "headline": "Revvity to Host Investor Day"
              },
              {
                "id": 142592011,
                "url": "https://finnhub.io/api/news?id=1354c9a3ac86acca82d61b1988ec9d31e1f0743e2810cf95605e1c46072883de",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity (RVTY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).",
                "category": "company",
                "datetime": 1790953202,
                "headline": "Revvity (RVTY) Upgraded to Buy: What Does It Mean for the Stock?"
              },
              {
                "id": 142588838,
                "url": "https://finnhub.io/api/news?id=20f528af1e1b120c026025dfda2cdf1c613fc223627e530195c33ed1dffc0e4d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "WALTHAM, Mass., October 02, 2026--Revvity, Inc. (NYSE: RVTY), today announced that it will release its third quarter 2026 financial results prior to market open on Tuesday, November 3, 2026. The Company will host a conference call the same day at 7:30 a.m. ET to discuss these results. Prahlad Singh, president and chief executive officer, and Max Krakowiak, chief financial officer, will host the conference call.",
                "category": "company",
                "datetime": 1790942400,
                "headline": "Revvity to Hold Earnings Call on November 3, 2026"
              },
              {
                "id": 142521568,
                "url": "https://finnhub.io/api/news?id=8796fb4f75396d1828b23a3b1b8c40d67fff4a675fd7b4ca8feac4460090c598",
                "image": "https://www.chartmill.com/images/uploads/CM_Unusual_Volume_Small_free_b9d2e60841.webp",
                "source": "ChartMill",
                "related": "RVTY",
                "summary": "Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Wednesday. Stay informed about the market activity below.",
                "category": "company",
                "datetime": 1790787900,
                "headline": "Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session."
              },
              {
                "id": 142499577,
                "url": "https://finnhub.io/api/news?id=ff4832de7ba97e9983ed854de2a013c27c693bf0523e62c4715efc273d08445c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity has been on fire lately. In the past six months alone, the company’s stock price has rocketed 78%, reaching $150.93 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.",
                "category": "company",
                "datetime": 1790700002,
                "headline": "Revvity (RVTY): Buy, Sell, or Hold Post Q2 Earnings?"
              },
              {
                "id": 142498306,
                "url": "https://finnhub.io/api/news?id=b99b47066bf1db0d53f43dfd46ad34ae8002db612643d2fa307c56c3e05fdaf9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "RVTY's diagnostics growth, AI-driven demand and life sciences expansion support its outlook, though China and margin pressures pose near-term challenges.",
                "category": "company",
                "datetime": 1790687520,
                "headline": "Here's Why You Should Retain Revvity Stock in Your Portfolio for Now"
              },
              {
                "id": 142463267,
                "url": "https://finnhub.io/api/news?id=fc9a13a952922c8e6a07e852b9dc7e22771cf21ad57968453bc3b6669662339b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.",
                "category": "company",
                "datetime": 1790586156,
                "headline": "1 Unpopular Stock That Deserves Some Love and 2 Facing Headwinds"
              },
              {
                "id": 142423965,
                "url": "https://finnhub.io/api/news?id=a9ff4d3ba263b75cc7992bb9bb5763803e41a2e984ca6e0e139ac9d5b22bbd62",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity launches a CE-IVDR-certified automated T1D screening kit for children, expanding its GSP platform from newborn screening into early childhood.",
                "category": "company",
                "datetime": 1790341740,
                "headline": "RVTY Launches New Kit in Europe for Newborn Type 1 Diabetes Detection"
              },
              {
                "id": 142423581,
                "url": "https://finnhub.io/api/news?id=6c773b4b4fd56046165f9f939d6d09120e989435edcb977079470afccf6c629d",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/movers_2.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "RVTY",
                "summary": "Revvity (NYSE:RVTY) reported second-quarter financial results on Tuesday. The transcript from the company's second-quarter earnings call has been provided below.\nThis content is powered by Benzinga APIs. For",
                "category": "company",
                "datetime": 1790313777,
                "headline": "Full Transcript: Revvity Q2 2026 Earnings Call"
              },
              {
                "id": 142385877,
                "url": "https://finnhub.io/api/news?id=0a10ab9058f099ea9dd8fed3a27d11f516b03ecf689b3ca7ecb544bfc4264f7b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Healthcare stocks were higher late Thursday afternoon, with the NYSE Healthcare Index increasing 0.9",
                "category": "company",
                "datetime": 1790280084,
                "headline": "Sector Update: Healthcare Stocks Advance Late Afternoon"
              },
              {
                "id": 142385317,
                "url": "https://finnhub.io/api/news?id=f6f2a26b9f5647288b5da04eda91284fe1679478b8b585e97013ed1ba637efe8",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "RVTY",
                "summary": "Stay updated with the movements of the S&P500 index one hour before the close of the markets on Thursday. Discover which stocks are leading as top gainers and losers in today's session.",
                "category": "company",
                "datetime": 1790276701,
                "headline": "Discover which S&P500 stocks are making waves on Thursday."
              },
              {
                "id": 142423582,
                "url": "https://finnhub.io/api/news?id=dbcf2dda78e5857b21e4ffb41aceed01250ceb475132a6bb612a945f2768a415",
                "image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_4.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "RVTY",
                "summary": "Revvity (NYSE:RVTY) has outperformed the market over the past 15 years by 1.11% on an annualized basis producing an average annual return of 14.72%. Currently, Revvity has a market capitalization of $16.82 billion.",
                "category": "company",
                "datetime": 1790271929,
                "headline": "Here’s How Much You Would Have Made Owning Revvity Stock In The Last 15 Years"
              },
              {
                "id": 142384739,
                "url": "https://finnhub.io/api/news?id=064fca65c12d5a6a144b02ffa288fa39c2b8d29421fbe717d8ae80b17cdacb6f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "All three major US stock indexes fell in late-morning trading Thursday amid uncertainty in the Middl",
                "category": "company",
                "datetime": 1790265971,
                "headline": "Top Midday Stories: Oracle's Data Center Delay; People Withdraws MGM Offer; Revvity's New Diabetes Test"
              },
              {
                "id": 142374834,
                "url": "https://finnhub.io/api/news?id=57a218c79f8db9c5829dc0b25bcf5d3d5d2d104a3cb88128bac31f9d804f3aa9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "WALTHAM, Mass., September 24, 2026--Revvity, Inc. (NYSE: RVTY) today announced the launch of the GSP® T1D 3plex kit, a fully automated, CE-IVDR-certified, multiplex autoantibody (AAb) detection solution to enable population-wide screening programs that identify children at risk of developing type 1 diabetes (T1D) before symptoms appear.",
                "category": "company",
                "datetime": 1790251200,
                "headline": "Revvity Launches IVDR-Certified Solution for Early Detection of Type 1 Diabetes"
              },
              {
                "id": 142379627,
                "url": "https://finnhub.io/api/news?id=6f5fae7103718fad61d71f792ffe7fcab9e945543672660195665d850dedefdd",
                "image": "",
                "source": "Benzinga",
                "related": "RVTY",
                "summary": "Revvity, Inc. (NYSE: RVTY) today announced the launch of the GSP® T1D 3plex kit, a fully automated, CE-IVDR-certified, multiplex autoantibody (AAb) detection solution to enable population-wide screening programs that",
                "category": "company",
                "datetime": 1790237027,
                "headline": "Revvity Rolls Out GSP T1D 3plex Kit"
              },
              {
                "id": 142363351,
                "url": "https://finnhub.io/api/news?id=08e21debb549e8d7bd2c4b8c5893e45852ed71ecc7711b290ef91bf21303ffcf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity has notably outperformed the Dow over the past year, and analysts are moderately optimistic about the stock’s prospects.",
                "category": "company",
                "datetime": 1790159593,
                "headline": "Is Revvity Stock Outperforming the Dow?"
              },
              {
                "id": 142350477,
                "url": "https://finnhub.io/api/news?id=cb58c8c8f2b541bcd7567cd8dc86f2dd0998a2a24d9e4da3258e8a9c57c37605",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity (RVTY) has drawn fresh attention after recent share price gains, with the stock up about 15% over the past month and roughly 36% over the past 3 months. Over the past year, Revvity has shifted from lagging long term returns, with a 5 year total shareholder return down 16.56%, to strong recent momentum. The 1 year total shareholder return reached 67.67%, and the 90 day share price return came in at 35.67%. Scan beyond Revvity's sharp rebound and explore other hand-picked opportunities...",
                "category": "company",
                "datetime": 1790129530,
                "headline": "Why Revvity (RVTY) Is Getting Attention Today"
              },
              {
                "id": 142328474,
                "url": "https://finnhub.io/api/news?id=85efb7d8043da2785c44589fe07e464369b52343ea3a62c863b956ea862cb220",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "AI-enabled, microfluidic label-free detection is expanding in drug discovery, early diagnostics, food safety and environmental testing, driven by efficient, non-invasive, sustainable workflows.Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- \"Label-Free Detection - Global Strategic Business Report\" has been added to ResearchAndMarkets.com's offering.The global market for Label-Free Detection was valued at US$553 Million in 2024 and is projected to reach US$847 Million by 2030, growing at a CAGR of 7.4",
                "category": "company",
                "datetime": 1790065560,
                "headline": "Capitalize on the Label-Free Detection Market Shift: Track How Danaher, Sartorius, Agilent, Bruker and Revvity Are Disrupting R&D ROI and Reshaping Global Revenue Through 2030"
              },
              {
                "id": 142328487,
                "url": "https://finnhub.io/api/news?id=293df837bbb17c71cf269b411ac0010b830920bae67dc70e20edcee04009550a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "High-content screening is advancing drug discovery and personalized medicine, driven by 3D models, advanced imaging and automated analytics, with opportunities in cancer research and organoids.Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- \"High Content Screening (HCS) - Global Strategic Business Report\" has been added to ResearchAndMarkets.com's offering.The global market for High Content Screening (HCS) was valued at US$1.3 Billion in 2024 and is projected to reach US$2.2 Billion by 2030, growing",
                "category": "company",
                "datetime": 1790065140,
                "headline": "Capitalize on High Content Screening Disruption: Decode How Thermo Fisher Scientific, Danaher, Revvity, and Yokogawa Are Reshaping Global R&D ROI and Revenue"
              },
              {
                "id": 142269870,
                "url": "https://finnhub.io/api/news?id=97da2091fb37a98868cc4df2c623e9c31db2fd3283341dda1e7fd6b0739faf09",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2149954800/image_2149954800.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "RVTY",
                "summary": "U.S. stocks closed the week mixed as Treasury yields rose amid a Fed rate hike, and fears of AI development grew. Read more about this week's top events on Wall Street.",
                "category": "company",
                "datetime": 1789800247,
                "headline": "What Moved Markets This Week"
              },
              {
                "id": 142270772,
                "url": "https://finnhub.io/api/news?id=2fbac1a765a47bf212e99e40ad93c0b49a5ff423030f1a4db735d13f67e98fb2",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/18/Diesel-Prices-Cross-6.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "RVTY",
                "summary": "The Fed hiked for the first time since 2023; the 10-year yield touched 5.04%, and record diesel prices hit truckers and automakers.",
                "category": "company",
                "datetime": 1789747909,
                "headline": "Fed Raises Rates, Yields Hit 2007 Highs as Fuel Costs Set Records: This Week On Wall Street"
              },
              {
                "id": 142249608,
                "url": "https://finnhub.io/api/news?id=713a37af216447ec3bd78a404d516aab7a7639f9e3cf8a77d99b3839d2ffcb44",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or even a loyal Reddit fanbase.",
                "category": "company",
                "datetime": 1789719440,
                "headline": "1 Momentum  Stock with Promising Prospects and 2 Facing Headwinds"
              },
              {
                "id": 142198959,
                "url": "https://finnhub.io/api/news?id=568783958075196b65740530debea12cb32f6534984a1b55719ef4f7c7471b7c",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "RVTY",
                "summary": "Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session.",
                "category": "company",
                "datetime": 1789585501,
                "headline": "Explore the top gainers and losers within the S&P500 index in today's session."
              },
              {
                "id": 142188758,
                "url": "https://finnhub.io/api/news?id=03b1bbe1a346d39ced2120c20af628767c205f491c25a175a480c992424683c9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity (RVTY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.",
                "category": "company",
                "datetime": 1789550040,
                "headline": "Strength Seen in Revvity (RVTY): Can Its 9.1% Jump Turn into More Strength?"
              },
              {
                "id": 142167113,
                "url": "https://finnhub.io/api/news?id=b9533ba462e02bc4cdd69ebe009cce3b112c1338397a301218653d5b059ea426",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "RVTY",
                "summary": "Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.",
                "category": "company",
                "datetime": 1789499101,
                "headline": "Discover which S&P500 stocks are making waves on Tuesday."
              },
              {
                "id": 142162217,
                "url": "https://finnhub.io/api/news?id=c9e230170d179b85b200d044ccc0f27596b9851ed1649e5e94f0dc70a6ee1f7d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the research tools & consumables industry, including Revvity (NYSE:RVTY) and its peers.",
                "category": "company",
                "datetime": 1789479331,
                "headline": "Q2 Rundown: Revvity (NYSE:RVTY) Vs Other Research Tools & Consumables Stocks"
              },
              {
                "id": 142194774,
                "url": "https://finnhub.io/api/news?id=d1cab808ccf45cf13f1263e44cacc1adc587155103fca3659b6bbe4aa4db95f1",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/15/Stock-Market-Graph-Crashing-Down--Wall-S.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "RVTY",
                "summary": "The 10-year Treasury yield broke 5% for the first time since 2007 as WTI surged past $105 on Saudi pipeline outages, pressuring stocks ahead of the Fed.",
                "category": "company",
                "datetime": 1789478829,
                "headline": "10-Year Yield Tops 5%, Oil Storms Past $105: Stock Market Today"
              },
              {
                "id": 142165183,
                "url": "https://finnhub.io/api/news?id=41ebfd4b80544d2c7c619a56a61cee031e3049ed69310da56b5dd1c7a7151515",
                "image": "https://image.cnbcfm.com/api/v1/image/108326254-1782318177071-gettyimages-2213364616-img_9901.jpeg?v=1782318352&w=1920&h=1080",
                "source": "CNBC",
                "related": "RVTY",
                "summary": "These are the stocks posting the largest moves midday.",
                "category": "company",
                "datetime": 1789473808,
                "headline": "Stocks making the biggest moves midday: Skyworks Solutions, Axon, Dave & Buster's, Revvity & more"
              },
              {
                "id": 142164499,
                "url": "https://finnhub.io/api/news?id=a187851a3b32d0f518cf6a22cdf7cb457662bd37fcebf1db3d2d732edf49b488",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "RVTY",
                "summary": "Revvity, Inc. (RVTY) 2026 Global Healthcare Conference September 15, 2026 9:05 AM EDTCompany ParticipantsStephen Willoughby - Senior VP of Investor...",
                "category": "company",
                "datetime": 1789473097,
                "headline": "Revvity, Inc. (RVTY) Presents at 2026 Global Healthcare Conference Transcript"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 3,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.9,
            "source_article_count": 44,
            "discarded_article_count": 35
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 19.3,
        "grade": "一般",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 2.2,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 2.2,
            "vcp_reason": "波幅收縮(29.3%→12.6%);跌縮量(近10日3日);站上MA50;Ready=Y;Confirm=N",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 2088023.3333333333,
              "down_days": 4,
              "vcp_ready": true,
              "above_ma50": true,
              "avg_vol_10": 1738980,
              "avg_vol_20": 2133990,
              "avg_vol_30": 2088023.3333333333,
              "range_pct_10": 0.12636544978569914,
              "range_pct_20": 0.16915516972689737,
              "range_pct_30": 0.2931290612675934,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": true,
              "up_expand_days": 1,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.8328355206758545,
              "dist_to_20d_high": 0.06941347368421046,
              "down_shrink_days": 3,
              "breakout_level_20d": 166.25,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.4310915104740907
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0.8,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "較差",
        "items": {
          "position": {
            "score": 1.3,
            "details": {
              "atrPct": 3.9215949892317887,
              "turnoverUsdM": 367.40347522788,
              "liquidityPoints": 0.6,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.RVTY",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 142.5758,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 1,
              "rsi_score": 2,
              "macd_score": 1.5,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 7.8,
            "take_profit_price": 167.1981,
            "target_multiplier": 1.9,
            "technical_strength": 1.63,
            "take_profit_percent": 8.1
          },
          "positionPoints": 1.3,
          "stopLossPoints": 1.2,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 7.8431899784635775,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 6.0671,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 3.92
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "平衡",
      "score": 6,
      "value": 49.79
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.0272
    },
    "kdj": {
      "d": 43.57,
      "j": 30.98,
      "k": 39.37,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "入貨中",
      "score": 8,
      "value": 61.57
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 6,
      "trend": "有流入",
      "value": 14195788,
      "recentSlope": 95238.8,
      "previousSlope": 473520
    },
    "rsi": 56.12,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 165.4055,
      "position": "SAR喺價上",
      "distancePct": 6.91,
      "previousTrend": "下降"
    },
    "ma50": 135.3566,
    "macd": {
      "macd": 5.5304872906327205,
      "trend": "中性偏多",
      "signal": 6.3158500792342585,
      "histogram": -0.785362788601538
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 150.5339,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 24
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.12,
      "score": 6,
      "avgVolume": 2115039,
      "currentVolume": 2374788
    },
    "derived": {
      "ma20": 150.982,
      "ma50": 135.3566,
      "prevClose": 152.12,
      "avgVolume10": 1728079,
      "avgVolume20": 2115039,
      "changePercent": 1.7,
      "avgVolumeForScore": 2115039
    },
    "ma_cross": {
      "ma20": 150.982,
      "ma50": 135.3566,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 150.583,
      "prevMa50": 134.5628,
      "spreadPct": 11.54,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 142.2893,
      "upper": 159.6747,
      "position": "上半部"
    },
    "rsi_short": 55.06,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.12
    }
  }
}

Raw metrics JSON

{
  "close": 154.71,
  "volume": 2374788,
  "changePercent": 1.7
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.